questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Ischémie myocardique
Maladie coronarienne
Sténose coronarienne
Resténose coronaire
Resténose coronaire : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Resténose coronaire
Angiographie
Tests d'effort
Échographie intravasculaire
Angiographie
Resténose coronaire
Douleur thoracique
Essoufflement
Resténose coronaire
Scintigraphie cardiaque
Perfusion myocardique
Resténose coronaire
Angioplastie
Ischémie
Resténose coronaire
Symptômes
5
Douleur thoracique
Fatigue
Essoufflement
Asymptomatique
Resténose coronaire
Symptômes
Douleur thoracique
Sensation de serrement
Resténose coronaire
Symptômes
Variabilité
Resténose coronaire
Consultation médicale
Douleur thoracique
Resténose coronaire
Prévention
5
Prévention
Mode de vie sain
Facteurs de risque
Cholestérol
Prévention
Resténose coronaire
Exercice
Santé cardiaque
Prévention
Contrôles médicaux
Santé cardiaque
Prévention
Stress
Santé cardiaque
Resténose coronaire
Traitements
5
Revascularisation
Médicaments
Resténose coronaire
Stents
Stents médicamenteux
Resténose coronaire
Médicaments antiagrégants
Caillots
Resténose coronaire
Chirurgie de pontage
Resténose coronaire
Traitements
Surveillance
Tests d'effort
Resténose coronaire
Complications
5
Angine de poitrine
Infarctus du myocarde
Complications
Infarctus du myocarde
Resténose coronaire
Risque
Qualité de vie
Activité physique
Resténose coronaire
Complications
Gestion
Resténose coronaire
Douleurs thoraciques
Complications
Urgence médicale
Facteurs de risque
5
Tabagisme
Hypertension
Diabète
Âge
Risque
Resténose coronaire
Diabète
Risque
Resténose coronaire
Mode de vie sédentaire
Risque
Resténose coronaire
Stress
Hypertension
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Resténose coronaire : Questions médicales les plus fréquentes",
"headline": "Resténose coronaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Resténose coronaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-19",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Resténose coronaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sténose coronarienne",
"url": "https://questionsmedicales.fr/mesh/D023921",
"about": {
"@type": "MedicalCondition",
"name": "Sténose coronarienne",
"code": {
"@type": "MedicalCode",
"code": "D023921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.585.250.285"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Resténose coronaire",
"alternateName": "Coronary Restenosis",
"code": {
"@type": "MedicalCode",
"code": "D023903",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tommaso Gori",
"url": "https://questionsmedicales.fr/author/Tommaso%20Gori",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moa Pehrson",
"url": "https://questionsmedicales.fr/author/Moa%20Pehrson",
"affiliation": {
"@type": "Organization",
"name": "Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden."
}
},
{
"@type": "Person",
"name": "Giovanna Sarno",
"url": "https://questionsmedicales.fr/author/Giovanna%20Sarno",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Sciences Cardiology and Uppsala Clinical Research Center, Uppsala University Uppsala Sweden."
}
},
{
"@type": "Person",
"name": "Abigail Fraser",
"url": "https://questionsmedicales.fr/author/Abigail%20Fraser",
"affiliation": {
"@type": "Organization",
"name": "Population Health Science, Bristol Medical School University of Bristol Bristol United Kingdom."
}
},
{
"@type": "Person",
"name": "Janet W Rich-Edwards",
"url": "https://questionsmedicales.fr/author/Janet%20W%20Rich-Edwards",
"affiliation": {
"@type": "Organization",
"name": "Division of Women's Health Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston MA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neuropsychology and Movement Disorders.",
"datePublished": "2024-06-17",
"url": "https://questionsmedicales.fr/article/39343477",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ncl.2024.05.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabinoids in movement disorders.",
"datePublished": "2022-08-24",
"url": "https://questionsmedicales.fr/article/36038457",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Moving Beyond Movement: Diagnosing Functional Movement Disorder.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36893796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1763505"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impaired Metacognition of Voluntary Movement in Functional Movement Disorder.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36606550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29303"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35787539",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000001075"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ischémie myocardique",
"item": "https://questionsmedicales.fr/mesh/D017202"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladie coronarienne",
"item": "https://questionsmedicales.fr/mesh/D003327"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sténose coronarienne",
"item": "https://questionsmedicales.fr/mesh/D023921"
},
{
"@type": "ListItem",
"position": 7,
"name": "Resténose coronaire",
"item": "https://questionsmedicales.fr/mesh/D023903"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Resténose coronaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Resténose coronaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Resténose coronaire",
"description": "Comment diagnostique-t-on la resténose coronaire ?\nQuels examens sont utilisés pour évaluer la resténose ?\nQuels symptômes peuvent indiquer une resténose ?\nLa scintigraphie cardiaque est-elle utile ?\nQuand faut-il suspecter une resténose après une angioplastie ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Movement+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Resténose coronaire",
"description": "Quels sont les symptômes courants de la resténose ?\nLa resténose peut-elle être asymptomatique ?\nComment la douleur thoracique se manifeste-t-elle ?\nLes symptômes varient-ils selon les patients ?\nQuand consulter un médecin pour des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Movement+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Resténose coronaire",
"description": "Comment prévenir la resténose coronaire ?\nLe contrôle du cholestérol aide-t-il à prévenir la resténose ?\nL'exercice régulier est-il bénéfique ?\nLes contrôles médicaux réguliers sont-ils importants ?\nLe stress peut-il influencer la resténose ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Movement+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Resténose coronaire",
"description": "Quels traitements sont disponibles pour la resténose ?\nLes stents sont-ils efficaces contre la resténose ?\nQuel rôle jouent les médicaments antiagrégants ?\nLa chirurgie est-elle une option pour la resténose ?\nComment la surveillance post-interventionnelle est-elle effectuée ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Movement+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Resténose coronaire",
"description": "Quelles complications peuvent survenir avec la resténose ?\nLa resténose augmente-t-elle le risque d'infarctus ?\nComment la resténose affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Movement+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Resténose coronaire",
"description": "Quels sont les principaux facteurs de risque de resténose ?\nL'âge influence-t-il le risque de resténose ?\nLe diabète est-il un facteur de risque ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress peut-il aggraver les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D023903?mesh_terms=Movement+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la resténose coronaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est diagnostiquée par angiographie coronarienne et tests d'effort."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer la resténose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie et l'échographie intravasculaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une resténose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques ou un essoufflement peuvent signaler une resténose."
}
},
{
"@type": "Question",
"name": "La scintigraphie cardiaque est-elle utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à détecter des zones de mauvaise perfusion myocardique."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une resténose après une angioplastie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si le patient présente des symptômes d'ischémie dans les mois suivant l'intervention."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la resténose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, fatigue et essoufflement à l'effort."
}
},
{
"@type": "Question",
"name": "La resténose peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients ne présentent aucun symptôme malgré la resténose."
}
},
{
"@type": "Question",
"name": "Comment la douleur thoracique se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être ressentie comme une pression ou une sensation de serrement dans la poitrine."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'un patient à l'autre."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter immédiatement en cas de douleur thoracique persistante."
}
},
{
"@type": "Question",
"name": "Comment prévenir la resténose coronaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, l'arrêt du tabac et la gestion des facteurs de risque sont essentiels."
}
},
{
"@type": "Question",
"name": "Le contrôle du cholestérol aide-t-il à prévenir la resténose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un taux de cholestérol sain réduit le risque de resténose."
}
},
{
"@type": "Question",
"name": "L'exercice régulier est-il bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la santé cardiaque et peut prévenir la resténose."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de surveiller la santé cardiaque et d'ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer la resténose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les problèmes cardiaques et favoriser la resténose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la resténose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la revascularisation, les médicaments et la surveillance."
}
},
{
"@type": "Question",
"name": "Les stents sont-ils efficaces contre la resténose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les stents, surtout les stents médicamenteux, réduisent le risque de resténose."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les médicaments antiagrégants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à prévenir la formation de caillots et à réduire le risque de resténose."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour la resténose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas, une chirurgie de pontage peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Comment la surveillance post-interventionnelle est-elle effectuée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle implique des contrôles réguliers et des tests d'effort pour évaluer la fonction cardiaque."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la resténose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'angine de poitrine, l'infarctus du myocarde et l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "La resténose augmente-t-elle le risque d'infarctus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la resténose peut augmenter le risque d'infarctus du myocarde."
}
},
{
"@type": "Question",
"name": "Comment la resténose affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut limiter l'activité physique et entraîner des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques sévères, des sueurs ou des nausées doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de resténose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de resténose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de resténose augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète augmente significativement le risque de resténose."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire contribue à l'augmentation du risque de resténose."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber d'autres facteurs de risque comme l'hypertension."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Sciences Cardiology and Uppsala Clinical Research Center, Uppsala University Uppsala Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Population Health Science, Bristol Medical School University of Bristol Bristol United Kingdom.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Division of Women's Health Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston MA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Perinatal and Cardiovascular Epidemiology Lund University Diabetes Centre, Clinical Sciences Malmö, Lund University Malmö Sweden.
Department of Obstetrics and Gynecology Skåne University Hospital Malmö Sweden.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: samin.sharma@mountsinai.org.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
School of Medicine, The University of Western Australia, Perth, WA 6009, Australia.
Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948954, Iran.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Del. Tlalpan, 14080, Mexico City, Mexico. gvargas63@yahoo.com.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. Electronic address: ron.waksman@medstar.net.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Unit of Interventional Cardiology, Mediterranea Cardiocentro, Naples, Italy.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
Publications dans "Resténose coronaire" :
2 publications dans cette catégorie
Affiliations :
Carle Heart & Vascular Institute, Carle Illinois College of Medicine, University of Illinois UC, Champaign, Illinois. Electronic address: imoussa@illinois.edu.
Publications dans "Resténose coronaire" :
Neuropsychology is important in differential diagnosis, treatment planning, surgical work-up, and support of patients with movement disorders and their families. The cognitive profiles of several move...
On the basis of both scientific progress and popular lore, there is growing optimism in the therapeutic potential of cannabis (marijuana) and cannabinoid-based chemicals for movement disorders. There ...
In recognition of the high interest and controversial nature of this subject, the meeting committee of the International Parkinson and Movement Disorders Society arranged for a talk on cannabis at the...
The endocannabinoid system is strongly tied to motor function and dysfunction, with basic research suggesting several promising therapeutic targets related to cannabinoids for movement disorders. Clin...
Further research is greatly needed to better understand the actual clinical benefits and long-term side effects of medical cannabis products for movement disorders indications and populations....
Functional movement disorder (FMD) is a complex neuropsychiatric syndrome, encompassing abnormal movements and weakness, and is a common cause of potentially disabling neurological symptoms. It is vit...
Motor symptoms in functional movement disorders (FMDs) are experienced as involuntary but share characteristics of voluntary action. Clinical and experimental evidence indicate alterations in monitori...
The objective of this study was to test the prediction that FMDs are associated with a reduced ability to make accurate (metacognitive) judgments about self-performed movements....
We compared 24 patients with FMD (including functional gait disturbance, functional tremor, and functional tics) with 24 age- and sex-matched healthy control subjects in a novel visuomotor-metacogniti...
Patients and control subjects showed comparable motor performance, response accuracy, and use of the confidence scale. However, visuomotor sensitivity in the trajectory judgment was reduced in patient...
Patients with FMD exhibited deficits both when making visuomotor decisions about their own movements and in the metacognitive evaluation of these decisions. Reduced metacognitive insight into voluntar...
The purpose of this review is to outline the impact of the COVID-19 pandemic on movement disorder holistic care, particularly in the care of people with Parkinson disease (PWP)....
As the pandemic unfolds, a flurry of literature was published regarding the impact of COVID-19 on people with Parkinson disease including the direct impact of infection, availability of ambulatory car...
COVID-19 has impacted the care of PWP in numerous ways. Recognizing infection in PWP poses challenges. Specific long-term complications, including emerging reports of long COVID syndrome is a growing ...
Drug-induced movement disorders (DIMDs) are most commonly associated with typical and atypical antipsychotics. However, other drugs such as antidepressants, antihistamines, antiepileptics, antiarrhyth...
Post-stroke movement disorders (PSMD) encompass a wide array of presentations, which vary in mode of onset, phenomenology, response to treatment, and natural history. There are no evidence-based guide...
To survey current opinions and practices on the diagnosis and treatment of PSMD....
A survey was developed by the PSMD Study Group, commissioned by the International Parkinson's and Movement Disorders Society (MDS). The survey, distributed to all members, yielded a total of 529 respo...
Parkinsonism (68%), hemiballismus/hemichorea (61%), tremor (58%), and dystonia (54%) were by far the most commonly endorsed presentation of PSMD, although this varied by region. Basal ganglia stroke (...
Regionally varying opinions and practices on PSMD highlight gaps in (and mistranslation of) epidemiologic and therapeutic knowledge. Multicenter registries and prospective community-based studies are ...
The relationship between antiseizure drugs and movement disorders is complex and not adequately reviewed so far. Antiseizure drugs as a treatment for tremor and other entities such as myoclonus and re...
Hereditary or familial spastic paraplegias (SPG) comprise a group of genetically and phenotypically heterogeneous diseases characterized by progressive degeneration of the corticospinal tracts. The co...
To summarize the clinical descriptions of SPG that manifest with movement disorders or ataxias to assist the clinician in the task of diagnosing these diseases....
We conducted a narrative review of the literature, including case reports, case series, review articles and observational studies published in English until December 2022....
Juvenile or early-onset parkinsonism with variable levodopa-responsiveness have been reported, mainly in SPG7 and SPG11. Dystonia can be observed in patients with SPG7, SPG11, SPG22, SPG26, SPG35, SPG...
Patients with SPG may present with different forms of movement disorders such as parkinsonism, dystonia, tremor, myoclonus and ataxia. The specific movement disorder in the clinical manifestation of a...
Peripherally-induced movement disorders (PIMD) should be considered when involuntary or abnormal movements emerge shortly after an injury to a body part. A close topographic and temporal association b...
A comprehensive PubMed search through a broad range of keywords and combinations was performed in February 2023 to identify relevant articles for this narrative review....
The spectrum of the phenomenology of PIMD is broad and it encompasses both hyperkinetic and hypokinetic movements. Hemifacial spasm is probably the most common PIMD. Others include dystonia, tremor, p...
There is considerable heterogeneity among PIMD in terms of severity and nature of injury, natural course, association with pain, and response to treatment. As some patients may have co-existing functi...